| 447 | 0 | 101 |
| 下载次数 | 被引频次 | 阅读次数 |
目的:通过文献分析探讨老年肌少症的中医证候以及证素分布规律,为临床辨证论治提供理论依据。方法:检索中国知网、Pub Med以及万方数据库中有关肌少症中医证候的临床研究文献,筛选并提取文献中证素、基础证候及症状信息,应用Excel表建立数据库并进行频数分析,运用SPSS、Origin和Gephi软件进行因子、聚类及复杂网络分析。结果:最终纳入71篇文献,经标准化后获得中医证型51种,涉及病性证素14个,病位证素9个。证型分布以脾胃虚证、脾肾亏虚证为主;虚性病性证素主要为气虚、阴虚、阳虚、精亏、血虚,实性病性证素主要为湿、血瘀、热、痰;病位证素主要为脾、肾、胃、肝、经络。核心症状体征为倦怠乏力、肢体痿软、神疲、纳呆、肌肉萎缩、便溏、腰膝酸软、气短、舌淡、脉细。证素聚类为5类:脾胃气虚证、肝肾亏虚证、阴阳两虚证、湿热浸淫证、痰瘀互结证。结论:老年肌少症基本病机为脾胃亏虚,证候呈现虚实夹杂特征,以虚证为主,湿热、痰瘀为重要病理产物。
Abstract:Objective: To explore the traditional Chinese medicine(TCM) syndromes and the distribution patterns of syndrome elements in elderly sarcopenia through literature analysis,providing a theoretical basis for clinical syndrome differentiation and treatment. Methods: Clinical research literature on TCM syndromes of sarcopenia was retrieved from CNKI,Pub Med,and Wanfang databases. Syndrome elements,basic syndromes and symptom information were screened and extracted from the literature. An Excel database was established and frequency analysis was performed,while factor analysis,cluster analysis,and complex network analysis were conducted using SPSS,Origin,and Gephi software. Results: A total of 71 studies were ultimately included. After standardization,51 types of TCM syndromes were identified,involving 14 pathogenic factors and 9 lesion locations. The distribution of syndromes was mainly characterized by SpleenStomach deficiency and Spleen-Kidney deficiency syndromes; deficiency-related pathogenic factors were primarily Qi deficiency,Yin deficiency,Yang deficiency,Essence deficiency,and blood deficiency,while excess-related syndrome elements were mainly Dampness,blood stasis,Heat,and Phlegm; lesion locations were mainly the Spleen,Kidney,Stomach,Liver,and meridians. Core symptoms and signs included fatigue,weakness of limbs,lassitude,poor appetite,muscle atrophy,loose stools,soreness of the waist and knees,shortness of breath,pale tongue,and thin pulse. Pathogenic factor clustering resulted in five categories: Spleen-Stomach Qi deficiency syndrome,Liver-Kidney deficiency syndrome,Yin-Yang deficiency syndrome,Damp-Heat infiltration syndrome,and Phlegm-stasis interlocking syndrome. Conclusion: The fundamental pathogenesis of sarcopenia in the elderly is Spleen-Stomach deficiency. The syndromes show a mixture of deficiency and excess in characteristics,mainly deficiency syndromes,while Damp-Heat and Phlegm-stasis are important pathological products.
[1]SAYER A A,COOPER R,ARAI H,et al. Sarcopenia[J].Nat Rev Dis Primers,2024,10:68.
[2]肌少症膳食营养处方及运动干预中国专家共识工作组.肌少症膳食营养处方及运动干预中国专家共识(2025)[J].营养学报,2025,47(1):1-11.
[3]郭秦,张伊祎,王玲,等.肌少症临床不良结局的研究进展[J].实用医院临床杂志,2024,21(4):172-175.
[4]CHEN L K,WOO J,ASSANTACHAI P,et al. Asian working group for sarcopenia:2019 consensus update on sarcopenia diagnosis and treatment[J]. J Am Med Dir Assoc,2020,21(3):300-307.
[5]国家市场监督管理总局,国家标准化管理委员会.GB/T16751. 2—2021中医临床诊疗术语第2部分:证候[S].北京:中国标准出版社,2021.
[6]朱文锋.证素辨证学[M].北京:人民卫生出版社,2008:162-229.
[7]张雪妍,闫海峰,李晓辉,等.基于科学知识图谱的证候演变规律研究可视化分析[J].中西医结合心脑血管病杂志,2024,22(19):3470-3476.
[8]张佳乐,张逸雯,王孟秋,等.中医证候诊断标准研制现状与思考[J].中华中医药杂志,2024,39(1):33-38.
[9]冯贞贞,李建生.中医证候疗效评价量表研制现状[J].中医学报,2022,37(12):2628-2635.
[10]陈树东,林方政,田瑞敏,等.基于“肌肉濡渍”探讨肌少症的中医发病机制及防治措施[J].中医正骨,2023,35(9):71-75.
[11]陈丹丹,沈贤发.浅谈调肝益脾法在肌少症患者中的应用[J].江西中医药大学学报,2024,36(1):1-4.
[12]李文雄,钟源,李智斌,等.基于气血理论探讨原发性肌少症的中医药防治策略[J].中国医药科学,2024,14(21):80-83.
[13]詹云帆,柴永利,严华美,等.上海社区老年人肌少症中医证候调查研究[J].上海中医药杂志,2025,59(2):49-54.
[14]汪潇,王新华,宋文蔚,等.156例老年肌少症中医证候分布规律研究[J].浙江中医杂志,2022,57(8):553-555.
[15]郭敬,刘斌,陈琳,等.基于辨机论治探讨核心症状群在中药新药研发中的应用[J].中国中医基础医学杂志,2025,31(8):1369-1372.
[16]代飞,张君宇,朱才丰,等.中西医防治老年肌少症的研究进展[J].世界中医药,2024,19(4):590-593.
[17]任爽,刘妍彤,张杰,等.痰湿现代医学本质述析[J].中国中医基础医学杂志,2021,27(9):1515-1518.
[18]孙淼,王玉艳,孟小钰,等.基于“肾虚、痰湿、血瘀”的现代生物学基础探讨PCOS中医病机的科学内涵[J].时珍国医国药,2022,33(6):1412-1415.
[19]景少博,张建平,李建国,等.基于中医瘀血理论探讨骨质疏松症中医发病机制认识及治疗进展[J].中国骨质疏松杂志,2021,27(2):275-278.
[20]郑剑,李勇,于青侠,等.《黄帝内经》“去宛陈莝”理论内涵及应用研究进展[J].中医药学报,2021,49(8):87-90.
基本信息:
DOI:10.16368/j.issn.1674-8999.2025.12.390
中图分类号:R274.9
引用信息:
[1]刘喜红,艾斯米热·克力木,都美羽,等.老年肌少症中医证候、证素特征分析[J].中医学报,2025,40(12):2492-2496.DOI:10.16368/j.issn.1674-8999.2025.12.390.
基金信息:
河南省科技攻关资助项目(252102520042,242102310497,242102310521); 河南省中医药科学研究专项课题项目(2025ZKY007,2025ZY1030,2024ZY2157,2024ZY1027); 豫药全产业链研发河南省协同创新中心开放课题项目(2024YYXT-KFKT-05)